These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21664969)

  • 1. The use of in situ near infrared spectroscopy to provide mechanistic insights into gel layer development in HPMC hydrophilic matrices.
    Avalle P; Pygall SR; Gower N; Midwinter A
    Eur J Pharm Sci; 2011 Aug; 43(5):400-8. PubMed ID: 21664969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrogating erosion-based drug liberation phenomena from hydrophilic matrices using near infrared (NIR) spectroscopy.
    Avalle P; Pygall SR; Pritchard J; Jastrzemska A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):72-9. PubMed ID: 23059372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence.
    Asare-Addo K; Levina M; Rajabi-Siahboomi AR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):452-60. PubMed ID: 20729043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets.
    Devjak Novak S; Šporar E; Baumgartner S; Vrečer F
    J Pharm Biomed Anal; 2012 Jul; 66():136-43. PubMed ID: 22510313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
    Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
    Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of water penetration and drug concentration profiles in HPMC-based matrix tablets by near infrared chemical imaging.
    Li W; Woldu A; Araba L; Winstead D
    J Pharm Sci; 2010 Jul; 99(7):3081-8. PubMed ID: 20112431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity.
    Viridén A; Larsson A; Schagerlöf H; Wittgren B
    Int J Pharm; 2010 Nov; 401(1-2):60-7. PubMed ID: 20883761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.